Cholesterol-embolization syndrome: current perspectives.
Ozkok A.
Vasc Health Risk Manag. 2019 Jul 8;15:209-220. doi: 10.2147/VHRM.S175150. eCollection 2019.
Low cholesterol syndrome and drug development.
Handhle A, Viljoen A, Ramachandran R, Wierzbicki AS.
Curr Opin Cardiol. 2020 Jul;35(4):423-427. doi: 10.1097/HCO.0000000000000745.
Cholesterol microembolization syndrome.
Kay JM.
CMAJ. 2010 Oct 19;182(15):1647; author reply 1647. doi: 10.1503/cmaj.110-2114.
The role of long noncoding RNA in lipid, cholesterol, and glucose metabolism and treatment of obesity syndrome.
Lu Q, Guo P, Liu A, Ares I, Martínez-Larrañaga MR, Wang X, Anadón A, Martínez MA.
Med Res Rev. 2021 May;41(3):1751-1774. doi: 10.1002/med.21775. Epub 2020 Dec 24.
Cholesterol crystal embolization.
Morales JM, Gonzalez E.
Blood Purif. 2006;24(5-6):431-2. doi: 10.1159/000095358. Epub 2006 Aug 25.
GPR183 antagonism reduces macrophage infiltration in influenza and SARS-CoV-2 infection.
Foo CX, Bartlett S, Chew KY, Ngo MD, Bielefeldt-Ohmann H, Arachchige BJ, Matthews B, Reed S, Wang R, Smith C, Sweet MJ, Burr L, Bisht K, Shatunova S, Sinclair JE, Parry R, Yang Y, Lévesque JP, Khromykh A, Rosenkilde MM, Short KR, Ronacher K.
Eur Respir J. 2023 Mar 9;61(3):2201306. doi: 10.1183/13993003.01306-2022. Print 2023 Mar.
A cholesterol deficiency syndrome in humans.
Connor WE.
J Clin Invest. 1995 Jan;95(1):2. doi: 10.1172/JCI117639.
Cholesterol emboli syndrome.
Liput JH.
W V Med J. 1989 Dec;85(12):532-5.
Cholesterol metabolism in pediatric short bowel syndrome after weaning off parenteral nutrition.
Pakarinen MP, Kurvinen A, Gylling H, Miettinen TA, Pesonen M, Kallio M, Koivusalo AI, Nissinen MJ.
Dig Liver Dis. 2010 Aug;42(8):554-9. doi: 10.1016/j.dld.2010.01.003. Epub 2010 Jun 9.
Cholesterol metabolism in the RSH/Smith-Lemli-Opitz syndrome: summary of an NICHD conference.
Opitz JM, de la Cruz F.
Am J Med Genet. 1994 May 1;50(4):326-38. doi: 10.1002/ajmg.1320500406.
